Journal of Hematology & Oncology

official impact factor 2.93

Open Access Review

First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

Andrea Molckovsky and Lillian L Siu*

Journal of Hematology & Oncology 2008, 1:20 doi:10.1186/1756-8722-1-20

No comments have yet been made on this article.

Post a comment